Delivery Order SPE2DB20D1050-SPE2DB24FH86Q
Award Date
8/26/24
Potential Completion Date
8/27/24
Potential Value
$1.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB20D7066|SPE2DB25FC2DP, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,203.28 firm-fixed-price delivery order is for the supply of JOLESSA 0.15 MG-0.03 MG TABLET 91S, a pharmaceutical product. The contract has an ultimate completion date of January 28, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of JOLESSA 0.15 MG-0.03 MG TABLET 91S. The contract, valued at $2,096.58, is a Firm Fixed Price Delivery Order with an ultimate completion date of August 2, 2024. AmerisourceBergen, a for-profit organization, has been awarded this contract without any set-aside designation. As a large supplier of pharmaceutical products and medical...
This federal contract award SPE2DB20D7059|SPE2DB24FQMP9 is a $5,926.47 firm-fixed-price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of JOLESSA 0.15 MG-0.03 MG TABLET 91S. The award has a completion date of September 16, 2024. Amerisourcebergen is a major pharmaceutical distributor that provides a wide range of medical products and supplies to various government agencies, including the DLA, through its extensive federal contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,155.72, is for a Firm Fixed Price Delivery Order to provide JOLESSA 0.15 MG-0.03 MG TABLET 91S, a type of prescription medication. The contract has an ultimate completion date of June 11, 2025 and is not set aside for any particular business type. AmerisourceBergen Drug Corp holds a significant...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JOLESSA 0.15 MG-0.03 MG TABLET 91S, a pharmaceutical product. The contract has a firm fixed price of $1,432.08 and a period of performance ending on May 28, 2025. The contract is not set-aside and is open to full and open competition. AmerisourceBergen Drug Corp holds...
This federal contract award, with ID SPE2DB22D3004|SPE2DB25FPN02, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,062.82, is for the delivery of JOLESSA 0.15 MG-0.03 MG TABLET 91S, a pharmaceutical product. The contract is a Delivery Order and has a Firm Fixed Price pricing type. It does not have a set-aside designation, indicating open competition....
The U.S. Defense Logistics Agency (DLA) awarded a $5,871.06 firm-fixed price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is to provide the drug product JOLESSA 0.15 MG-0.03 MG TABLET 91S to DLA facilities. Amerisourcebergen also holds a $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical to deliver a comprehensive range of pharmaceutical products and medical supplies to support the...
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $237.23 to Amerisourcebergen Drug Corporation for the supply of 4561522540 JOLESSA 0.15 MG-0.03 MG TABLET 91S. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the requested pharmaceutical products from its place of performance in Conshohocken, Pennsylvania within the period of performance between July 17-18, 2023. The Defense Logistics Agency utilizes numerous contracts to support the...
This is a $1,663.68 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the delivery of 4565221558 JOLESSA 0.15 MG-0.03 MG TABLET 91S, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which provides a comprehensive range of medical commodities to support military treatment...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, the prime contractor, for the delivery of Jolessa 0.15 mg-0.03 mg tablets. The contract is a firm fixed price delivery order with a ceiling value of $1,019.54 and a performance period through March 25, 2024. AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation, is providing these pharmaceutical products to support military...